The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - AstraZeneca
A phase I study of AK112, a bispecific antibody that targets PD-1 and VEGF co-expressing T cells, in patients with advanced solid tumors.
 
Jermaine Coward
Honoraria - Takeda
Research Funding - MedImmune
 
Charlotte Rose Lemech
No Relationships to Disclose
 
Anna Rachelle Austria Mislang
No Relationships to Disclose
 
Sagun Parakh
No Relationships to Disclose
 
Craig Underhill
Research Funding - Bristol-Myers Squibb (Inst)
 
Adnan Nagrial
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Research Funding - Akeso Biopharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Xiaoping Jin
No Relationships to Disclose
 
Baiyong Li
No Relationships to Disclose
 
Zhongmin Maxwell Wang
No Relationships to Disclose
 
Kon Yew Kwek
Employment - Akeso Biopharma; IQvia; Lilly
Stock and Other Ownership Interests - Lucence Diagnostics
 
Yu Xia
No Relationships to Disclose